about
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market...
Read More
3.28
0.00
(0.00%)
45,642
XNAS Volume
XNAS 21 Jul, 2025 1:29 PM (EDT)
Board Meeting
The next board meeting for Alzamend Neuro Inc is on 30 Jul 2025 for the purpose of Alzamend Neuro Inc Annual Report for 2025
See details
Not Eligible
Expensive Valuation
Technically Bearish
Alzamend Neuro Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..